Sunflower

Sunflower Therapeutics is a biotech company dedicated to democratizing access to biologics through innovative manufacturing technologies. The company's core offering is the Daisy platform, an automated, small-scale, end-to-end system designed for the rapid development and production of proteins and vaccines. By leveraging yeast-based expression systems and modular hardware, Sunflower enables decentralized manufacturing, allowing medicines to be produced closer to the point of need. Their approach significantly reduces the capital intensity and complexity traditionally associated with biopharmaceutical production. As a Public Benefit Corporation, Sunflower focuses on global health equity by providing tools that make essential medicines more affordable and accessible worldwide.